PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:08 AM ET

Sponsor Check › Person

JH
No photo found yet (own website and image search run after this page is viewed)

Jim Heppell

Named as an officer, director or promoter on SEC Form D filings · British Columbia, Canada (as filed: A1), CA · Jul 20, 2009 → Sep 1, 2022

9deals (issuers)
$80.5Mreported sold
112investors
21Form D filings
2009–2022years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Jim Heppell is listed as an executive officer and director on 21 SEC Form D filings by 9 issuers between Jul 2009 and Sep 2022. Largest by amount reported sold: Skye Bioscience, Inc. (San Diego, CA — biotechnology — 2018; $62.3M reported sold to 43 investors), Emerald Health Sciences Inc. (Vancouver, British Columbia, Canada (as filed: A1) — industry reported as "Other" — 2022; $9.89M reported sold to 45 investors), SOPHIRIS BIO INC. (La Jolla, CA — biotechnology — 2019; $5.07M reported sold to 1 investors), Emerald Health Pharmaceuticals Inc. (San Diego, CA — pharmaceuticals — 2017; $2.5M reported sold to 5 investors), PROTOX THERAPEUTICS INC (Vancouver, British Columbia, Canada (as filed: A1) — biotechnology — 2010; $226K reported sold to 3 investors) and 4 more (all listed below).

What this means A repeat sponsor — 9 separate companies raised money with this person listed as executive officer and director, over about 13 years. Across those companies the filings report $80.5M sold in total.

Listed alongside Gaetano Morello (8 shared filings), Stephen Hall (6 shared filings), Punit Dhillon (5 shared filings), Charles Cook (4 shared filings), Derek Spratt (4 shared filings) and 48 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jim. Each name links to their own page.

3 of the issuers belong to the sponsor group Emerald Health (3 issuers, $712K reported sold, 2017–2022).

What this means A sponsor group is one team that sets up a new company for each deal. Emerald Health has 3 companies on file and $712K reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 21 public filings for Jim Heppell and found 10 differences, 4 worth asking the sponsor about: Paid seller listed without a CRD number: Canaccord Financial Ltd; Paid seller listed without a CRD number: Versant Partners Inc; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Jim Heppell has not run yet — it is joining a line of 7,593 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

1 case: 1 closed (disposition not in docket feed)

Heppell v. U.S. Citizenship and Immigration Services (USCIS) closed
District Court, N.D. Illinois · No. 1:23-cv-00506 · Filed Jan 26, 2023 · Closed Feb 10, 2023
Role of Heppell: Plaintiff · Outcome: Terminated 2023-02-10 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (2 people in Form D filings, 1 federal dockets); surname only in the caption; court in IL (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Jim Heppell..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

10 differences found between the filings for Jim Heppell — 4 worth asking about (compared 21 filings on Oct 24, 2026)

Worth asking · Apr 15, 2010

Paid seller listed without a CRD number: Canaccord Financial Ltd. — PROTOX THERAPEUTICS INC

Canaccord Financial Ltd. is listed as receiving sales compensation on 1 filing (Apr 15, 2010) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Sources
Worth asking · Apr 15, 2010

Paid seller listed without a CRD number: Versant Partners Inc. — PROTOX THERAPEUTICS INC

Versant Partners Inc. is listed as receiving sales compensation on 1 filing (Apr 15, 2010) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Sources
Worth asking · Jul 1, 2009 – Sep 1, 2022

9 Form Ds were filed more than 15 days after the first sale

Form D filed 1,332 days after the first sale — Emerald Health Sciences Inc. · Form D filed 1,962 days after the first sale — Emerald Health Sciences Inc. · Form D filed 2,436 days after the first sale — Emerald Health Sciences Inc. · Form D filed 2,610 days after the first sale — Emerald Health Sciences Inc. · Form D filed 2,803 days after the first sale — Emerald Health Sciences Inc. · and 4 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Sources
Worth asking · Jan 25, 2018 – Feb 23, 2018

Jim Heppell is no longer listed on the Feb 23, 2018 amendment — Skye Bioscience, Inc.

Jim Heppell appears on the Jan 25, 2018 Form D (director) but not on the Feb 23, 2018 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Sources
Note · Jan 25, 2018 – Feb 23, 2018

Offering amount changed between filings — Skye Bioscience, Inc.

The Jan 25, 2018 filing says $6,800,000 offered; the Feb 23, 2018 Form D/A says $8,570,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Jul 27, 2017 – Aug 17, 2017

Offering amount changed between filings — Emerald Health Bioceuticals Inc.

The Jul 27, 2017 filing says $23,740 offered; the Aug 17, 2017 Form D/A says $127,006.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Jul 20, 2009 – Apr 7, 2010

Offering amount lowered between filings — MSI METHYLATION SCIENCES, INC.

The Jul 20, 2009 filing says $7,500 offered; the Apr 7, 2010 Form D says $6,800.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Sources
Note · Mar 16, 2010 – Mar 19, 2020

4 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Emerald Health Bioceuticals Inc. (latest filing Mar 19, 2020) · No amendment in the last 12 months on an offering that may still be open — Mobidia Technology Inc. (latest filing Nov 10, 2014) · No amendment in the last 12 months on an offering that may still be open — Mobidia Technology Inc. (latest filing Feb 19, 2014) · No amendment in the last 12 months on an offering that may still be open — PROTOX THERAPEUTICS INC (latest filing Apr 15, 2010)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Sources
Note · Jul 27, 2017 – Mar 19, 2020

Industry group changed between filings — Emerald Health Bioceuticals Inc.

"Biotechnology" (Jul 27, 2017 to Aug 17, 2017); then "Retailing" (Mar 19, 2020).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Sources
Note · Jul 20, 2009 – Sep 1, 2022

Jim Heppell is listed with 2 different address states: A1, CA

British Columbia, Canada (as filed: A1) on 15 filings (Jul 20, 2009 to Sep 1, 2022); CA on 6 filings (Mar 14, 2017 to Mar 19, 2020).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

2 of 19 offerings report sales commissions totalling $255,848; 0 report finder's fees; 0 report proceeds to related persons.

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Sep 1, 2022 D
Emerald Health Sciences Inc.
File 021-457764
$0$0$0None listed on this filingEDGAR ↗
Sep 1, 2022 D
Emerald Health Sciences Inc.
File 021-457767
$0$0$0None listed on this filingEDGAR ↗
Sep 1, 2022 D
Emerald Health Sciences Inc.
File 021-457769
$0$0$0None listed on this filingEDGAR ↗
Sep 1, 2022 D
Emerald Health Sciences Inc.
File 021-457770
$0$0$0None listed on this filingEDGAR ↗
Sep 1, 2022 D
Emerald Health Sciences Inc.
File 021-457772
$0$0$0None listed on this filingEDGAR ↗
Sep 1, 2022 D
Emerald Health Sciences Inc.
File 021-457775
$0$0$0None listed on this filingEDGAR ↗
Mar 19, 2020 D
Emerald Health Bioceuticals Inc.
File 021-363301
$0$0$0None listed on this filingEDGAR ↗
Sep 6, 2019 D
SOPHIRIS BIO INC.
File 021-348192
$240,000$0$0H.C. Wainwright & Co., LLC BrokerCheck CRD 375 ↗EDGAR ↗
Jan 25, 2018 D
Skye Bioscience, Inc.
File 021-304091
$0$0$0None listed on this filingEDGAR ↗
Aug 17, 2017 D/A
Emerald Health Bioceuticals Inc.
File 021-291607
$0$0$0None listed on this filingEDGAR ↗
Mar 14, 2017 D
Emerald Health Pharmaceuticals Inc.
File 021-282486
$0$0$0None listed on this filingEDGAR ↗
Nov 10, 2014 D
Mobidia Technology Inc.
File 021-228005
$0$0$0None listed on this filingEDGAR ↗
Feb 19, 2014 D
Mobidia Technology Inc.
File 021-212125
$0$0$0None listed on this filingEDGAR ↗
Nov 6, 2013 D
Contech Enterprises, Inc.
File 021-205844
$0$0$0None listed on this filingEDGAR ↗
Sep 17, 2013 D
Mobidia Technology Inc.
File 021-203042
$0$0$0None listed on this filingEDGAR ↗
Jan 4, 2013 D
Mobidia Technology Inc.
File 021-189474
$0$0$0None listed on this filingEDGAR ↗
Oct 12, 2010 D
PROTOX THERAPEUTICS INC
File 021-148815
$0$0$0None listed on this filingEDGAR ↗
Apr 15, 2010 D
PROTOX THERAPEUTICS INC
File 021-140657
$15,848$0$0Dundee Securities Corp. no CRD number reported
via Dundee Securites Inc. (CRD 39759 ↗)

Canaccord Financial Ltd. no CRD number reported
Versant Partners Inc. no CRD number reported
EDGAR ↗
Apr 7, 2010 D
MSI METHYLATION SCIENCES, INC.
File 021-113659
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 9

Every issuer that named Jim Heppell on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Other · group: Emerald Health

Emerald Health Sciences Inc.

Vancouver, British Columbia, Canada (as filed: A1) · Sep 1, 2022 → Sep 1, 2022 · 6 filings
  • Sep 1, 2022 · D · $360,000 sold of $360,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Sep 1, 2022 · D · $4,015,359 sold of $4,015,359 · 45 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Sep 1, 2022 · D · $9,886,884 sold of $9,886,884 · 39 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Sep 1, 2022 · D · $392,956 sold of $392,956 · 5 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Sep 1, 2022 · D · $500,430 sold of $500,430 · 10 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Sep 1, 2022 · D · $65,509 sold of $65,509 · 6 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $9.89M from 45 investors (100% of the $360K target) as of the latest filing. Jim is listed as executive officer, director on 6 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Retailing · group: Emerald Health

Emerald Health Bioceuticals Inc.

San Diego, CA · Jul 27, 2017 → Mar 19, 2020 · 3 filings
  • Mar 19, 2020 · D · $52,000 sold of $5,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 17, 2017 · D/A · $127,006 sold of $127,006 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 27, 2017 · D · $23,740 sold of $23,740 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $127K from 8 investors (3% of the $5M target) as of the latest filing. Jim is listed as director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Retailing / 506(b) (959 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

SOPHIRIS BIO INC.

La Jolla, CA · Sep 6, 2019
  • Sep 6, 2019 · D · $5,066,667 sold of $5,066,667 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $5.07M from 1 investor (100% of the $5.07M target) as of the latest filing. Jim is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals

Skye Bioscience, Inc.

San Diego, CA · Jan 25, 2018
  • Jan 25, 2018 · D · $2,400,000 sold of $6,800,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $62.3M from 43 investors (100% of the $6.8M target) as of the latest filing. Jim is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals · group: Emerald Health

Emerald Health Pharmaceuticals Inc.

San Diego, CA · Mar 14, 2017
  • Mar 14, 2017 · D · $1,000 sold of $1,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $2.5M from 5 investors (100% of the $1,000 target) as of the latest filing. Jim is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Technology

Mobidia Technology Inc.

Richmond, British Columbia, Canada (as filed: A1) · Jan 4, 2013 → Nov 10, 2014 · 4 filings
  • Nov 10, 2014 · D · $21,936 sold of $35,097 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 19, 2014 · D · $24,314 sold of $38,901 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 17, 2013 · D · $48,005 sold of $48,005 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 4, 2013 · D · $124,233 sold of $124,233 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $194K from 4 investors (100% of the $35K target) as of the latest filing. Jim is listed as director on 4 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other

Contech Enterprises, Inc.

Victoria, British Columbia, Canada (as filed: A1) · Nov 6, 2013
  • Nov 6, 2013 · D · $200,000 sold of $200,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $200K from 1 investor (100% of the $200K target) as of the latest filing. Jim is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

PROTOX THERAPEUTICS INC

Vancouver, British Columbia, Canada (as filed: A1) · Apr 15, 2010 → Oct 12, 2010 · 2 filings
  • Oct 12, 2010 · D · $0 sold of $59,431,399 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 15, 2010 · D · $226,398 sold of $404,352 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $226K from 3 investors (0% of the $59.4M target) as of the latest filing. Jim is listed as director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Biotechnology

MSI METHYLATION SCIENCES, INC.

Burnaby, British Columbia, Canada (as filed: A1) · Jul 20, 2009 → Apr 7, 2010 · 2 filings
  • Apr 7, 2010 · D · $6,800 sold of $6,800 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 20, 2009 · D · $0 sold of $7,500 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $20K from 2 investors (100% of the $6,800 target) as of the latest filing. Jim is listed as director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Jim 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

GM
No photo found yet (own website and image search run after this page is viewed)
Person

Gaetano Morello

Director, Executive Officer · 8 shared filings (3 issuers)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

SH
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Hall

Executive Officer · 6 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

PD
No photo found yet (own website and image search run after this page is viewed)
Person

Punit Dhillon

Director · 5 shared filings (3 issuers) · also on 1 other issuer

Listed on the same filings as Jim Heppell. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

Derek Spratt

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

CC
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Cook

Director · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Jim Heppell. Their page shows their other deals.

KT
No photo found yet (own website and image search run after this page is viewed)
Person

Kent Thexton

Director · 4 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

RN
No photo found yet (own website and image search run after this page is viewed)
Person

Robert E. Neal

Director · 4 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

AD
No photo found yet (own website and image search run after this page is viewed)
Person

Avtar Dhillon

Director, Executive Officer · 3 shared filings (2 issuers) · also on 3 other issuers

Avtar Dhillon is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

Jill Broadfoot

Executive Officer · 3 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Jim Heppell. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

Jay D. Kranzler

Director · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

NH
No photo found yet (own website and image search run after this page is viewed)
Person

Nancy Harrison

Executive Officer, Promoter · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jim Heppell. Their page shows their other deals.

JF
No photo found yet (own website and image search run after this page is viewed)
Person

Joshua Freedman

Promoter · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

BG
No photo found yet (own website and image search run after this page is viewed)
Person

Barry J. Guld

Director, Executive Officer, Promoter · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Patrick R. Brady

Director · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

NA
No photo found yet (own website and image search run after this page is viewed)
Person

Nazmin Alani

Director · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

TO
No photo found yet (own website and image search run after this page is viewed)
Person

Tom D'Orazio

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

FM
No photo found yet (own website and image search run after this page is viewed)
Person

Fahar Merchant

Executive Officer, Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Jim Heppell. Their page shows their other deals.

AG
No photo found yet (own website and image search run after this page is viewed)
Person

Alexander Giaquinto

Director · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

Jack Geltosky

Director · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

NM
No photo found yet (own website and image search run after this page is viewed)
Person

Nina Merchant

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

FH
No photo found yet (own website and image search run after this page is viewed)
Person

Frank Holler

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Jim Heppell. Their page shows their other deals.

JP
No photo found yet (own website and image search run after this page is viewed)
Person

John Parkinson

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Jim Heppell. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

James Miller

Director · 2 shared filings (1 issuer) · also on 7 other issuers

James Miller is on 8 issuers in total — a repeat sponsor. Their page lists every one.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Jacques Denommee

Director · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

DD
No photo found yet (own website and image search run after this page is viewed)
Person

Dr. Avtar Dhillon

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

Jade Beutler

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Dr. Gaetano Morello

Director · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

KL
No photo found yet (own website and image search run after this page is viewed)
Person

Karim Lalji

Director · 2 shared filings (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

BM
No photo found yet (own website and image search run after this page is viewed)
Person

Brian S. Murphy

Executive Officer, Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Jim Heppell. Their page shows their other deals.

HD
No photo found yet (own website and image search run after this page is viewed)
Person

Howard David

Director · 1 shared filing (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

SD
No photo found yet (own website and image search run after this page is viewed)
Person

Samuel Denmeade

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

DH
No photo found yet (own website and image search run after this page is viewed)
Person

David Howard

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Jim Heppell. Their page shows their other deals.

CF
No photo found yet (own website and image search run after this page is viewed)
Person

Christian H. Fibiger

Director · 1 shared filing (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

JZ
No photo found yet (own website and image search run after this page is viewed)
Person

John Zaplatynsky

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Jim Heppell. Their page shows their other deals.

CH
No photo found yet (own website and image search run after this page is viewed)
Person

Chris Hill

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

CW
No photo found yet (own website and image search run after this page is viewed)
Person

Chris Welsh

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Allen Spigelman

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

John Borden

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

CB
No photo found yet (own website and image search run after this page is viewed)
Person

Carol Burman

Director · 1 shared filing (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Cary Gregory

Director · 1 shared filing (1 issuer)

Listed on the same filings as Jim Heppell. Their page shows their other deals.

The team behind the deals

Sponsor group

Emerald Health

3 issuers · 13 filings · $712K reported sold · 2017–2022

One team, 3 deal companies. Jim Heppell is listed on 3 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Jim Heppell.

Registrations and other filings

Adviser registration (Form ADV)

None of the 9 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Jim Heppell by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 9 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Jim Heppell is listed on: none on file. No website or social profile named in SOPHIRIS BIO INC.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #229,869 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (La Jolla, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Jim Heppell appears on a new Form D, or when a court case or SEC action is matched to them. See plans →